Abatacept Pregnancy Exposure Registry

Completed

Conditions studied: Rheumatoid Arthritis

In brief

The purpose of the abatacept pregnancy registry is to monitor planned and unplanned pregnancies exposed to abatacept, to evaluate the possible teratogenic effects (that is, any abnormal development) of this medication in the pregnancy outcome and to follow live born infants for one year after birth.

Key facts

Study ID

NCT01087125

Run by

Bristol-Myers Squibb

People needed

42

Starts

2006-09-01

Expected to finish

2019-12-31

Last updated by the study team

2023-07-20

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Currently pregnant women who agree to the conditions and requirements of the study including the interview schedule, release of medical records, and the physical examination of live born infants

You may not qualify if…

• Women who come in first contact with the project after prenatal diagnosis of a fetal abnormality

Where it is running

• Bristol-Myers Squibb, Active — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.